Department of Internal Medicine III, Cardiology, Angiology and Pneumology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Clin Res Cardiol. 2019 Feb;108(2):194-202. doi: 10.1007/s00392-018-1343-y. Epub 2018 Aug 6.
Calcification of aortic valve and mitral annulus is associated with cardiovascular risk factors, morbidity and mortality. Assessment of cardiac calcification with echocardiography is feasible, however, only few structured scoring systems have been established so far with limited prognostic data. This study aimed to evaluate an echocardiographic calcification score (echo-CCS) in patients with low/intermediate cardiovascular risk.
Digitally stored echocardiography studies of 151 patients (median age 64, 49.7% male) from February 2008 to December 2009 were retrospectively reviewed for calcifications of the aortic valve, aortic root, mitral annulus, papillary muscles and ventricular septum. A calcification score ranging from 0 to 5 was assigned to every patient and its relation to computed tomography calcium score, coronary stenosis and ESC SCORE was assessed. Follow-up data were collected from 149 patients (98.7%) with a median of 6.2 years. Logistic regression and Kaplan-Meier analysis were performed to assess the association of the echo-CCS with significant coronary artery disease (≥ 50% stenosis) and risk for cardiac events and all-cause mortality.
An association of the echo-CCS with the ESC SCORE (ρ = 0.5; p < 0.001) and a good correlation of the echo-CCS with the Agatston score (ρ = 0.73; p < 0.001) can be observed. Univariate regressions revealed that echo-CCS is a significant predictor for cardiac events [OR = 5.1 (CI: 1.7-15.0); p = 0.003], coronary intervention [OR = 2.8 (CI: 1.3-5.7); p = 0.006], hospitalisation for cardiac symptoms [OR = 2.0 (CI: 1.2-3.4); p = 0.007], all-cause mortality [OR = 2.6 (CI: 1.3-5.5); p = 0.01] and significant CAD [OR = 3.2 (CI: 1.9-5.4); p < 0.001].
We demonstrated the prevalence of an easily obtainable, radiation-free calcification score in patients with low/intermediate cardiovascular risk. The strong association with CT-calcium scoring may evoke its potential as an alternative method in CV risk assessment.
主动脉瓣和二尖瓣环的钙化与心血管危险因素、发病率和死亡率有关。超声心动图评估心脏钙化是可行的,但迄今为止仅建立了少数几个结构化评分系统,且预后数据有限。本研究旨在评估低/中危心血管风险患者的超声心动图钙化评分(echo-CCS)。
回顾性分析 2008 年 2 月至 2009 年 12 月 151 例患者(中位年龄 64 岁,49.7%为男性)的数字存储超声心动图研究资料,评估主动脉瓣、主动脉根部、二尖瓣环、乳头肌和室间隔的钙化情况。为每位患者分配 0 至 5 分的钙化评分,并评估其与计算机断层扫描钙评分、冠状动脉狭窄和 ESC SCORE 的关系。从 149 例患者(98.7%)中收集随访数据,中位随访时间为 6.2 年。采用逻辑回归和 Kaplan-Meier 分析评估 echo-CCS 与有意义的冠状动脉疾病(≥50%狭窄)和心脏事件及全因死亡率风险的关系。
可以观察到 echo-CCS 与 ESC SCORE 之间存在关联(ρ=0.5;p<0.001),且与 Agatston 评分具有良好的相关性(ρ=0.73;p<0.001)。单变量回归显示,echo-CCS 是心脏事件的显著预测因子[比值比(OR)=5.1(95%置信区间:1.7-15.0);p=0.003]、冠状动脉介入[OR=2.8(95%置信区间:1.3-5.7);p=0.006]、因心脏症状住院[OR=2.0(95%置信区间:1.2-3.4);p=0.007]、全因死亡率[OR=2.6(95%置信区间:1.3-5.5);p=0.01]和有意义的 CAD[OR=3.2(95%置信区间:1.9-5.4);p<0.001]。
我们在低/中危心血管风险患者中发现了一种容易获得的、无辐射的钙化评分,其与 CT 钙评分有很强的关联,这可能使其成为心血管风险评估的替代方法。